OPA1 and diabetic cardiomyopathy: Concerning the molecular mechanisms, a study by Chang et al has highlighted the PKG-STAT3-Opa1 pathway, describing it as a potent promoter of mitochondrial fusion in diabetic cardiomyopathy [14].